6365 results for "11+1双色球多少钱一注"

in 186.10 milliseconds.

• Targeted capture ctDNA Library CRCQV42Run044-24

  Targeted capture ctDNA Library CRCQV42Run044-24 from patient PBC0005531, plasma 9 month sample

  Dataset EGAD00001010674

• Targeted capture ctDNA Library CRCQV42Run044-4

  Targeted capture ctDNA Library CRCQV42Run044-4 from patient PBC0001048, plasma 6 month sample

  Dataset EGAD00001010675

• Targeted capture ctDNA Library CRCQV42Run044-5

  Targeted capture ctDNA Library CRCQV42Run044-5 from patient PBC0001099, plasma 6 month sample

  Dataset EGAD00001010676

• Targeted capture ctDNA Library CRCQV42Run045-15

  Targeted capture ctDNA Library CRCQV42Run045-15 from patient PBC0001714, plasma 3 month sample

  Dataset EGAD00001010686

• Targeted capture ctDNA Library CRCQV42Run045-19

  Targeted capture ctDNA Library CRCQV42Run045-19 from patient PBC0001311, plasma 3 month sample

  Dataset EGAD00001010690

• Targeted capture ctDNA Library CRCQV42Run045-21

  Targeted capture ctDNA Library CRCQV42Run045-21 from patient PBC0002651, plasma 3 month sample

  Dataset EGAD00001010692

• Targeted capture ctDNA Library CRCQV42Run045-22

  Targeted capture ctDNA Library CRCQV42Run045-22 from patient PBC0001456, plasma 6 month sample

  Dataset EGAD00001010693

• Targeted capture ctDNA Library CRCQV42Run045-23

  Targeted capture ctDNA Library CRCQV42Run045-23 from patient PBC0002481, plasma 3 month sample

  Dataset EGAD00001010694

• Targeted capture ctDNA Library CRCQV42Run045-24

  Targeted capture ctDNA Library CRCQV42Run045-24 from patient PBC0001409, plasma 3 month sample

  Dataset EGAD00001010695

• Targeted capture ctDNA Library CRCQV42Run045-4

  Targeted capture ctDNA Library CRCQV42Run045-4 from patient PBC0002458, plasma 6 month sample

  Dataset EGAD00001010696

• Targeted capture ctDNA Library CRCQV42Run045-6

  Targeted capture ctDNA Library CRCQV42Run045-6 from patient PBC0004124, plasma 6 month sample

  Dataset EGAD00001010698

• Targeted capture ctDNA Library CRCQV42Run045-8

  Targeted capture ctDNA Library CRCQV42Run045-8 from patient PBC0006360, plasma 12 month sample

  Dataset EGAD00001010700

• Targeted capture ctDNA Library CRCQV42Run046-21

  Targeted capture ctDNA Library CRCQV42Run046-21 from patient PBC0001828, plasma 9 month sample

  Dataset EGAD00001010712

• Targeted capture ctDNA Library CRCQV42Run046-23

  Targeted capture ctDNA Library CRCQV42Run046-23 from patient PBC0002622, plasma 9 month sample

  Dataset EGAD00001010714

• Targeted capture ctDNA Library CRCQV42Run046-24

  Targeted capture ctDNA Library CRCQV42Run046-24 from patient PBC0002494, plasma 3 month sample

  Dataset EGAD00001010715

• Targeted capture ctDNA Library CRCQV42Run046-4

  Targeted capture ctDNA Library CRCQV42Run046-4 from patient PBC0001776, plasma 3 month sample

  Dataset EGAD00001010716

• Targeted capture ctDNA Library CRCQV42Run046-5

  Targeted capture ctDNA Library CRCQV42Run046-5 from patient PBC0001242, plasma 3 month sample

  Dataset EGAD00001010717

• Targeted capture ctDNA Library CRCQV42Run046-9

  Targeted capture ctDNA Library CRCQV42Run046-9 from patient PBC0002769, plasma 6 month sample

  Dataset EGAD00001010721

• STAG1-ChIP-Seq of STAG2-mutated and cohesin wildtype adult AMLs

  ChIPseq targeting the cohesin subunit STAG1 in STAG2-mutated AMLs or cohesin wildtype AMLs

  Dataset EGAD00001011206

• SNF_RNAseq_CD138p_20

  TPM matrices of counts from RNA sequencing (RNAseq) from baseline CD138+ enriched BM fractions.

  Dataset EGAD00001011148

• Covacta OLINK LOD

  Explore 1536 dataset from serum of patients enrolled in the COVACTA trial. This dataset includes limit of detection values provided by Olink.

  Dataset EGAD00001011161

• SF11310

  SF11310 Oligodendroglioma, IDH-mutant.Tumor Location: Frontal. Age:22. Sex: Female

  Dataset EGAD00001006313

• Targeted capture ctDNA Library CRCQV34Run015-13

  Targeted capture ctDNA Library CRCQV34Run015-13 from patient PBC0002459, plasma 9 month sample

  Dataset EGAD00001010379

• Targeted capture ctDNA Library CRCQV42Run031-7

  Targeted capture ctDNA Library CRCQV42Run031-7 from patient PBC0001295, buffy coat sample

  Dataset EGAD00001010535

• Targeted capture ctDNA Library CRCQV42Run033-15

  Targeted capture ctDNA Library CRCQV42Run033-15 from patient PBC0002533, buffy coat sample

  Dataset EGAD00001010554

• Targeted capture ctDNA Library CRCQV42Run036-5

  Targeted capture ctDNA Library CRCQV42Run036-5 from patient PBC0001470, plasma 30 month sample

  Dataset EGAD00001010603

• Targeted capture ctDNA Library CRCQV42Run039-7

  Targeted capture ctDNA Library CRCQV42Run039-7 from patient PBC0002853, plasma 6 month sample

  Dataset EGAD00001010623

• Targeted capture ctDNA Library CRCQV42Run043-9

  Targeted capture ctDNA Library CRCQV42Run043-9 from patient PBC0001306, plasma 6 month sample

  Dataset EGAD00001010659

• Targeted capture ctDNA Library CRCQV42Run044-8

  Targeted capture ctDNA Library CRCQV42Run044-8 from patient PBC0001376, plasma 6 month sample

  Dataset EGAD00001010679

• Targeted capture ctDNA Library CRCQV42Run045-7

  Targeted capture ctDNA Library CRCQV42Run045-7 from patient PBC0005444, plasma 18 month sample

  Dataset EGAD00001010699

• Targeted capture ctDNA Library CRCQV42Run046-7

  Targeted capture ctDNA Library CRCQV42Run046-7 from patient PBC0001528, plasma 6 month sample

  Dataset EGAD00001010719

• Targeted capture ctDNA Library CRCQV42Run42-7

  Targeted capture ctDNA Library CRCQV42Run42-7 from patient PBC0001299, plasma 15 month sample

  Dataset EGAD00001010831

• Targeted capture ctDNA Library CRCQV42Run42-8

  Targeted capture ctDNA Library CRCQV42Run42-8 from patient PBC0003385, plasma 15 month sample

  Dataset EGAD00001010832

• TXT_CD138P_15

  TPM matrices of counts from RNA sequencing (RNAseq) from longitudinal CD138+ enriched BM fractions.

  Dataset EGAD00001011144

• RNAseq and ATACseq on HGSC lines, pre- and post-treatment with an epigenetic drug

  This study looked to determine changes in gene expression and chromatin accessibility of five HGSC cell lines, following treatment with a novel epigenetic drug. The epigenetic drug, HKMTi-1-005, is a compound with dual activity against H3K27 and H3K9 methylation. The cell lines used were PEO1, PEO4, PEA2, OVCAR5, OVCAR8.

  Study EGAS50000000047

• Bulk RNA-seq of monocytes and in vitro cultured monocyte-derived macrophages of ANCA-associated vasculitis patients with active and stable disease and healthy controls

  To study monocyte and macrophage activation in ANCA-associtated vasculitis (AAV), we performed bulk RNA sequencing of bead-selected monocytes and in vitro cultured monocyte-derived macrophages from AAV patients and healthy controls. Overview patients included for sequencing monocytes: - AAV active disease, n=4, MPO-AAV=4 - AAV remission, n=10, PR3-AAV=5, MPO-AAV=5 - Healthy controls, n=6 Overview patients included for sequencing monocyte-derived macrophages: - AAV active, n=1, PR3-AAV=1 - AAV remission, n=3, PR3-AAV=3 - Healthy controls, n=3

  Dataset EGAD50000000450

• ChIP-seq analysis of clear cell renal cell carcinoma

  In order to understand the epigenetic basis on ccRCC, we performed ChIP-seq on 3 ccRCC cell lines (786-O, A498, UMRC-2), and 1 normal kidney epithelium cell line (HK-2), cultured under normoxic (20% O2) and hypoxic (0.05% O2) conditions. This study analysed data from H3k4me1, H3K4me3, H3K27ac, H3k27me3, H3k36me3, CTCF, and HIF1A

  Study EGAS50000001322

• Common origin and somatic mutation patterns of composite lymphomas and leukemias

  The dataset contains six composite lymphomas and leukemias cases (four composite B-cell lymphomas (case 1-4), and two combinations of B-cell and T-cell lymphoma (case 5+6)). Two tumor and one non-tumor (NTC) sample were sequenced from each case after library prep with NEBNext Ultra DNA Library Prep Kit, Exome capturing was done with NimbleGen SeqCap EZ Choice kit, and sequenced on a Illumina HiSeq 2000 HO and given as fastq files. WGA (Qiagen REPLI-g kit) was used for case 2 and 3. Case 1-4 were microdisected, case 5+6 were flow-sorted.

  Dataset EGAD50000001486

• Copy-choice recombination during mitochondrial L-strand synthesis causes DNA deletions

  The dataset comprises of seven samples described below 1. Muscle samples from three patients with late-onset PEO caused by compound heterozygous POLG variants M0305 POLG W748S/R1096C M1105 POLG A467T/T251I+P587L M1804 POLG A467T/X1240G+35aa 2. Muscle sample from a patient with adPEO with heterozygous TWNK variants M0230 TWNK p.Arg357Pro 3. Blood control samples from two patients with late-onset PEO caused by compound heterozygous POLG variants DNA2012-1630_S1 POLG W748S/R1096C DNA2018-0168_S2 POLG A467T/T251I+P587L 4. Muscle samples from healthy control individuals DNA2018-0172_S4 Healthy control 2 DNA2018-0173_S5 Healthy control 1

  Dataset EGAD00001004271

• NABUCCO cohort 1 (NCT03387761) - Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy

  NABUCCO cohort 1 sequencing data. The dataset includes: * Whole exome DNAseq pre-treatment on tumor samples (n=24) matched with blood samples (n=24) * RNAseq pre-treatment on tumor samples (n=18) * RNAseq post-treatment on tumor samples (n=18). Not all pre-treatment samples are linked with pre-treatment samples * High coverage Whole exome DNAseq on pre-treatment tumor samples (n=3) matched with post-treatment metastasized lymph nodes isolated with laser microdissection (n=3) * All samples are labelled with the response phenotype (Complete Responder or Non-Complete Responder)

  Dataset EGAD00001006250

• Multi-region RNA-Seq data of 10 neuroblastoma cases

  To investigate intratumour heterogeneity and to better understand tumour evolution in neuroblastoma, we have performed a multi-region RNA sequencing on a total of 51 spatially separated tumor samples from 9 primary neuroblastomas (2 low-risk, 1 intermediate-risk and 6 high-risk) and 1 relapsed neuroblastoma. We also assessed the impact of chemotherapy on the clonal expansion by sequencing tumour regions from one medium risk and one high-risk tumour for which we had matched samples obtained at diagnosis and after chemotherapy.

  Dataset EGAD00001008133

• OA_hip-G-1

  Genotyping of hip osteoarthritis patients who have undergone total joint replacement

  Dataset EGAD00010001292

• HGP-clean

  Himalayan population genetic study QC filtered data

  Dataset EGAD00010001471

• stilts-G-1

  Human Core Exome Genotyping for 1471 samples from the STudy Into Lean and Thin Subjects (STILTS) cohort

  Dataset EGAD00010001622

• Single cell RNA-Seq of Clear Cell Sarcoma of the Kidney

  Dataset EGAD00001007498

• Reference epigenome SMC01_ChIP-Seq(H3K27me3) data generated from KEP study

  A SMC01_ChIP-Seq(H3K27me3) paired end data for skeletal muscle cells

  Dataset EGAD00001003845

• Reference epigenome SMC02_WGBS data generated from KEP study

  A SMC02_WGBS paired end data for skeletal muscle cells

  Dataset EGAD00001003872

• Reference epigenome SMC03_ChIP-Seq(H3K27me3) data generated from KEP study

  A SMC03_ChIP-Seq(H3K27me3) paired end data for skeletal muscle cells

  Dataset EGAD00001003847

• Reference epigenome SMC05_ChIP-Seq(H3K27me3) data generated from KEP study

  A SMC05_ChIP-Seq(H3K27me3) paired end data for skeletal muscle cells

  Dataset EGAD00001003849

• Reference epigenome SMC06_ChIP-Seq(H3K27me3) data generated from KEP study

  A SMC06_ChIP-Seq(H3K27me3) paired end data for skeletal muscle cells

  Dataset EGAD00001003850